Zhangjiagang CIMC Sanctum Cryogenic Equipment, a subsidiary of CIMIC Enric Holdings, has started research and development (R&D) of liquid nitrogen biological containers to meet the needs of the biomedical industry, including the long-term cryogenic storage of Covid-19 vaccines.
Alongside the Covid-19 vaccine, the Chinese company said its development will also help the storage of stem cells, plasma, semen, embryos and various tissues and organs.
The liquid nitrogen biological container will be designed on the GN14174 large-caliber liquid nitrogen container standard. Upon successful development, the equipment will adopt advanced technologies such as high vacuum multilayer insulation, electronic temperature control, and liquid nitrogen dispersion to make the intelligent cooling and constant temperature process uniform and stable.
It is expected that the product will provide immersion storage and vapor phase storage in two ways, providing users with a fully automatic, safe and reliable cryogenic liquid nitrogen storage system.
... to continue reading you must be subscribed
